BroadOak Capital vs Leerink Partners
Comparing two boutique M&A advisors · Last updated April 12, 2025
| Attribute | BroadOak Capital | Leerink Partners |
|---|---|---|
| Type | Industry specialist | Industry specialist |
| HQ | Atlanta, GA | Boston, MA |
| Founded | 2008 | 1995 |
| Sector focus | Healthcare, Lower Mid-Market | Healthcare, Biotech |
| Deal size | $5M-$50M | $25M-$1B |
| Senior team |
|
|
| Rating | Locked | Locked |
| Reviews | 0 verified | 0 verified |
Choosing between BroadOak Capital and Leerink Partners
BroadOak Capital and Leerink Partners both work in Healthcare. Founders running a sell-side process in those categories often see both names on their advisor longlist, which is why this comparison comes up. Both firms position themselves as industry specialist advisors, so the choice is less about category and more about pattern recognition, senior attention, and process fit.
BroadOak Capital is headquartered in Atlanta, GA and was founded in 2008, while Leerink Partners operates out of Boston, MA and was founded in 1995. Geography matters here: BroadOak Capital's Atlanta relationships and Leerink Partners's Boston relationships will overlap on national strategics but diverge on the regional private equity buyer set most likely to push price. On deal-size focus, BroadOak Capital states $5M-$50M while Leerink Partners states $25M-$1B. Beyond shared coverage, BroadOak Capital also reaches into Lower Mid-Market, while Leerink Partners extends into Biotech.
For founders deciding between BroadOak Capital and Leerink Partners, the honest recommendation is to take a working session with each named partner before signing. Read the firm-level reviews on BankerNotes for the pattern that matters most: did the partner who pitched the mandate run the buyer calls and final negotiations, or did the work slide down the org chart by week six. That pattern, more than league-table position, is what separates a good outcome from a mediocre one.
BroadOak Capital is a industry specialist headquartered in Atlanta, GA and founded in 2008. The firm focuses on Healthcare, Lower Mid-Market and typically advises on transactions in the $5M-$50M range. Key dealmakers inc...
Leerink Partners is a industry specialist headquartered in Boston, MA and founded in 1995. The firm focuses on Healthcare, Biotech and typically advises on transactions in the $25M-$1B range. Key dealmakers include Jeff ...
Frequently asked questions
- What is the main difference between BroadOak Capital and Leerink Partners?
- BroadOak Capital is a industry specialist HQ'd in Atlanta, GA (founded 2008), focused on Healthcare, Lower Mid-Market, with a typical deal range of $5M-$50M. Leerink Partners is a industry specialist HQ'd in Boston, MA (founded 1995), focused on Healthcare, Biotech, with a typical deal range of $25M-$1B. Beyond those facts, the most reliable differentiator is senior banker attention, which BankerNotes reviews are designed to surface.
- Which firm has better founder reviews, BroadOak Capital or Leerink Partners?
- BroadOak Capital's current rating is Locked (reviews unlock after five verified founders submit ratings). Leerink Partners's current rating is Locked (reviews unlock after five verified founders submit ratings). Read the individual firm profiles for the full review breakdown.
- Should I shortlist both BroadOak Capital and Leerink Partners?
- For most founders evaluating sell-side advisors with overlapping sector and deal-size fit, putting both on a shortlist is reasonable. The point of a bake-off is to test how the senior team behaves under pressure, how the firm shapes the buyer universe, and how it handles a difficult diligence question. Treat the shortlist as an interview, not a beauty contest.
- How does BankerNotes verify reviews of BroadOak Capital and Leerink Partners?
- Every review is submitted by a founder who confirms they hired the firm as their sell-side advisor. We verify the reviewer privately using work email, LinkedIn, and approximate engagement timing. The verified identity is never published. Only the rating, written review, and a generic sector label appear on the public page.
Related advisor comparisons
Browse sectors covered
Last updated: April 12, 2025